Cargando…
Il costo a carico dei pazienti del percorso per eleggibilità ai farmaci PCSK9 e follow-up di un anno: i risultati dello Studio PRIOR
BACKGROUND: Several health care services are required to get eligibility to PCSK9-inhibitors medicines and the follow-up of patients being treated. The ultimate goal is making prescriptions appropriate and monitoring the effects of these drugs. Some recent papers (opinion/consensus documents) highli...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AboutScience
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768598/ https://www.ncbi.nlm.nih.gov/pubmed/36628306 http://dx.doi.org/10.33393/grhta.2022.2415 |